Literature DB >> 308506

Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods.

F A Drasar, W Farrell, A J Howard, C Hince, T Leung, J D Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 308506     DOI： 10.1093/jac/4.5.445

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  30 in total

1.  Clinical evaluation of the effect of cefotaxime in senile pneumonia caused by gram-positive and gram-negative bacteria.

Authors:  H Katsunuma
Journal:  Infection       Date:  1985       Impact factor: 3.553

2.  Human pharmacology of cefotaxime (HR 756), a new cephalosporin.

Authors:  R Lüthy; R Münch; J Blaser; H Bhend; W Siegenthaler
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

3.  Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds.

Authors:  H C Neu; N Aswapokee; K P Fu; P Aswapokee
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

4.  Comparison of activity and beta-lactamase stability of cefotaxime with those of six other cephalosporins.

Authors:  R P Mouton; G P Bongaerts; M van Gestel
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

5.  Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.

Authors:  T Kesado; K Watanabe; Y Asahi; M Isono; K Ueno
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

6.  Comparative activities of aztreonam and cefotaxime against Escherichia coli and Bacteroides spp. in pure and mixed cultures.

Authors:  F Soriano; M C Ponte
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

7.  Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.

Authors:  A Digranes; E Benonisen; W L Dibb
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

8.  Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics.

Authors:  T R Parr; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

9.  Hydrolysis of Cefotaxime by a beta-lactamase from Bacteroides fragilis.

Authors:  J C Pechère; R Guay; J Dubois; R Letarte
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

10.  Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.

Authors:  P R Murray
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.